Skip to content

Income Tax at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$44.7M+85.5%
Arrowhead Research logo
Arrowhead ResearchARWR
$7K-99.6%
AptarGroup logo
AptarGroupATR
$21M-23.2%
AbbVie logo
AbbVieABBV
$342M-8.1%
Alkermes logo
AlkermesALKS
$4.55M+50.5%
LQD
Liquidia CorporationLQDA

Other financials

Income statement

See full
Revenue$376.7M+42.2%
Gross profit$297.5M+37.4%
Operating income$184.5M+30.4%
Net income$150.0M+27.1%
EPS (diluted)$1.22+31.2%

Balance sheet

See full
Cash & equivalents$312.0M+76.9%
Total debt$2.2B+41.7%
Total equity$219.6M-54.5%
Total assets$2.7B+21.7%

Cash flow

See full
Operating cash flow$180.1M+16.8%
CapEx$3.7M+294%
Free cash flow$176.3M+15.0%

Valuation

See full
Market cap$8.13B-2.9%
Enterprise value$10B+3.0%
P/E13.4×-3.8×
P/S5.4×-2.3×

Profitability

See full
Gross margin82.8%-0.7pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin44.3%-1.5pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity9.9×+6.7×
Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Halozyme Therapeutics's income tax?
Halozyme Therapeutics (HALO) reported income tax of $30.28M in Q1 2026.
How has Halozyme Therapeutics's income tax changed year-over-year?
Halozyme Therapeutics's income tax increased by 17.7% year-over-year, from $25.73M to $30.28M.
What is the long-term trend for Halozyme Therapeutics's income tax?
Over 4 years (2021 to 2025), Halozyme Therapeutics's income tax has grown at a -0.7% compound annual growth rate (CAGR), from -$154.19M to $149.99M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.